Shire's ADHD drug Vyvanse succeeds in binge eating trial

Pharmaceutical group Shire PLC said Vyvanse, its amphetamine-based drug prescribed to U.S. students to control ADHD, had also been successful in treating binge eating disorder (BED) in a trial. It said it would submit an application to the U.S. drugs regulator, the FDA, for the approval of the drug for binge eating disorder after the results of the tests, which were completed earlier than expected. Shire's chief executive Flemming Ornskov, who joined the company earlier this year, said he was extremely pleased with the results. Shire said it would present the efficacy and safety data from both studies at a major scientific meeting next year, and it expected to file for FDA approval by the third quarter of 2014.



via Health News Headlines - Yahoo! News http://news.yahoo.com/shires-adhd-drug-vyvanse-succeeds-binge-eating-trial-083526045--finance.html